 Russell Investments Group Ltd. grew its holdings in Corcept Therapeutics Incorporated NASDAQ:CORT by 155.2 during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The fund owned 389,335 shares of the biotechnology companys stock after acquiring an additional 236,757 shares during the period. Russell Investments Group Ltd.s holdings ... 